New Cancer Detector

A groundbreaking device that can diagnose  cancer in just 20 minutes is being developed by British scientists.

The world’s first tumor profiler, as it is known, will allow doctors, nurses and pharmacists to quickly identify all known types of cancer while the patient waits.

It is hoped the device, which will also gauge the correct drug to prescribe cancer sufferers, will be used within the next three years.

A British company has developed a device that can diagnose cancer in just 20 minutes - and decide the best drug for treatment

The device has been invented as part of a partnership between private firm QuantuMDx, Newcastle University and Sheffield University.

Scientists say the Q-Cancer device will have a dramatic impact on the rapid and accurate diagnosis of cancer.

Company officials said the device has the potential to prolong the lives of the 12 million newly diagnosed cancer sufferers around the world.

It will enable surgeons to immediately remove most, if not all of the tumor, and allow cancer specialists to prescribe the correct treatment regime according to the type of cancer developed.

The device makes use of advanced nanotechnology, analyzing submicroscopic amounts of tissue to work out the type of cancer, its genetic make-up and how far it has developed.

Professor John Burn (left), a renowned geneticist, and Jonathan O'Halloran, both of QuantuMDx, the company developing the device
Professor John Burn (left), a renowned geneticist, and Jonathan O’Halloran, both of QuantuMDx, the company developing the device

Professor Sir John Burn, the Newcastle University academic who is also medical director of QuantuMDx, said: ‘We have a world leading position to deliver complex DNA tumor testing to the routine pathology lab or even to the operating theatre.

‘A low-cost device requiring no technical expertise will extract, amplify and analyze tumor DNA to make sure the patient gets the right treatment first time and without delay.’

Chief executive Elaine Warburton said:  ‘Currently tumor samples are sent away to a centralized sequencing laboratory, which can take several weeks to turnaround results, usually at a very high price which is not routinely affordable to many.

‘As far as we are aware, QuantuMDx’s current underlying technologies, which can break up a sample and extract the DNA in under five minutes represents a world first for complex molecular diagnostics.

Dr Emma Smith, Cancer Research UK’s senior  science information officer, said: ‘Using the latest technology to analyze tumors quickly and cheaply could make a real difference to cancer patients and we will watch these developments with interest. It will need thorough testing to show it meets the standards required  for routine use.’

Attribution: Anna Hodgekiss

Advertisements

About thecommonconstitutionalist

Brent is not a scholar. He’s not an author or speaker (yet). He hasn’t published a book nor does he write articles for magazines (yet). He has no advanced literary degree or pedigree (never will). He is just an American who writes and shares what interests him. He cares about the salvation of this country and a return to its Constitutional roots. He believes in God, country and family.
This entry was posted in Current Events, International, Medicine, Science & Technology and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s